Page 106 - Heca News Today

Moderna Inc on Thursday slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand, sending its shares tumbling 16%.

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.

Regeneron Pharmaceuticals Inc on Thursday reported higher-than-expected quarterly revenue on strong demand for its COVID-19 antibody cocktail during the Delta variant-led surge in infections in the United States.

The last two years have caused lasting damage to the U.S. workforce. A record 4.3 million people quitting their jobs in August is a big part of the problem. But the pandemic took its toll in other ways, too. Deaths caused by the virus, gun violence and drug overdoses exacerbated shortages. The damage could take years to repair.

Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization.

In his eighties, Mohammed Hadi al-Harmali has been uprooted four times by shifting frontlines during the seven years of Yemen's brutal civil war.

The Latvian parliament on Thursday allowed businesses to fire workers who refuse to either get a COVID-19 vaccine or transfer to remote work, as the country battles one of the worst COVID-19 waves in European Union.

Business groups, state attorneys general and religious organizations have promised swift court challenges to try to block the vaccine-and-testing mandate unveiled on Thursday by the Biden administration.

The City of Vienna said on Thursday it is banning people not vaccinated against COVID-19 from cafes, restaurants and events with more than 25 people, pre-empting measures that are likely to be introduced across Austria soon as infections are surging.

South Africa's Dis-Chem Pharmacies Ltd reported a 35.3% jump in half-year earnings on Wednesday, helped by pent-up demand for medicines and vaccines after the easing of pandemic lockdowns.